Topic Listing for AngioDynamics

Accountability Accounting Business Combinations Goodwill Intangible Assets
Accounts Receivable Accrual Mode Payment
Accrued Liabilities Accumulated Other Comprehensive Loss
Acquisition Certain Assets Diomed Acquisition Flowmedica Inc
Acquisition Oncobionic Acquisition Oncobionic Inc
Acquisition Oncobionicinc Acquisition Rita Medical Systems Inc
Acquisition Terms Acquisitions
Acquisitions Contd Additional Disclosures Related Settlement
Additional Information Acquisition Find Additional Information Merger Find
Ade Reporting Adjustment Provisions
Administration Adverse Reactions
Advertising Aggregated Option Exercises Year-end Value Table
Aggregated Option Sar Exercises Last Year-end Values Aggregated Option Sar Exercises Year-end Values
Agreement Agreement Former Director
Agreements Entered E-z-em Connection Initial Public Offering Restrict Agreements Former Parent
Albany New York Allocation Taxes
Allocations Former Parent Amendment
Amendment Agreement Plan Merger Amendment Angiodynamics 2004 Stock Incentive Award Plan
Amendment Angiodynamics 2004 Stock Incentive Award Plan Employee Amendment Angiodynamics Employee Stock Purchase Plan
Amendment Supply Distribution Rights Agreement Amendments
Amendments Articles Incorporation Bylaws Change Angiodynamics
Angiodynamics Acquire Rita Medical 220 Angiodynamics Appeal Patent Infringement Verdict
Angiodynamics Biolitec Wolfgang Neuberger Angiodynamics Inc
Angiodynamics Inc Nasdaq Ango Angiodynamics Names Robert Mitchell Chief Operating Officer
Angiodynamics Nasdaq Ango Angiodynamics Offers 2400000 Shares Common Stock
Angiodynamics Reports Strong Results Angiodynamics Vascular Solutions
Angiographic Products Accessories Ango
Animal Toxicology Annual Cash Incentives
Annual Equity Awards Annual Meeting Held 2008
Annual Meeting Held 2009 Annual Performance Evaluation
Annual Report Appointment Certain Officers Compensatory Arrangements
Arterial Adaptors Asset Purchase Agreement
Asset Purchase Agreements Assignment
At-will Employment Audit Committee Financial Expert
Audit Committee Report Available Information
B-comprehensive Income Back
Background Background Information
Backlog Base Salaries
Base Salary Basis Presentation Business Description Recent Events
Beneficial Ownership Reporting Compliance Benefits Rfa System
Bidding Procedures Blunt Insertion Tray
Board Compensation Committee Report Executive Board Directors
Board Directors Recommends Vote Each Following Proposals Board Directors Recommends Vote Each Proposals Below
Board Independence Bonus Payments
Borrower Business Harmed Interventional Cardiologists Perform Procedures Radiologists Vascular
Business Harmed Lose Services Key Personnel C-acquisitions
Cannot Obtain Maintain Approval Governmental Agencies Not Able Cannot Obtain Maintain Marketing Clearance Approval Governmental Agencies
Capitalization Carcinogenesis Mutagenesis Impairment Fertility
Cash Equivalents Cash Payments
Catheter Ceo Compensation
Ceo Transition Ceo Transition Costs
Certain Covenants Certain Relationships Related Transactions
Certification Change Control Agreement
Change Terms Agreement Change-in-control Severance Arrangements
Changes Internal Control Over Financial Reporting Changes Internal Controls Over Financial Reporting
Changes Reimbursement Levels Governmental Other Third-party Payors Procedures Chapa San Juanita Spohn Hospital Shoreline
Chedule Chedule Nderwriters
Cit Signers Class Directors Term Expiring 2008 Annual Meeting
Class Directors Term Expiring 2009 Annual Meeting Class Directors Term Expiring 2010 Annual Meeting
Class Directors Term Expiring 2011 Annual Meeting Clinical Pharmacology
Closing Closing Conditions
Closing Deliveries Code Business Conduct Ethics
Code Ethics Comments Injunction Ruling
Commercial Security Agreement Committees Board
Common Stock Common Stock Performance Graph
Communications Directors Compensation Committee
Compensation Committee Interlocks Insider Participation Decisions Compensation Committee Report Executive
Compensation Directors Compensation Philosophy Objectives
Compensation Stock Option Committee Report Executive Competing Products
Competition Competition Decrease Market Share Cause Revenues Decline
Completion Acquisition Disposition Assets Completion Guaranty
Compliance Laws Rules Regulations Compliance Reporting
Components Executive Compensation 2007 Composition
Comprehensive Income Conditions Closing
Conditions Precedent Performance Parties Conference Call
Conference Call Information Conference Call Presentation
Confidentiality Conflicts Interest
Consent Independent Registered Public Accounting Firm Consideration
Consolidated Balance Sheet Highlights Consolidated Balance Sheets
Consolidated Financial Statements Consolidated Financial Statements Statement Schedule
Consolidation Healthcare Industry Adverse Effect Revenues Results Operations Construction Installation Project Facility
Consulting Agreement Director Cont
Contd Continue Drive Growth Localized Therapy Products
Contraindications Controls Procedures
Convertible Notes Corporate Agreement
Corporate Governance Board Independence Committees Corporate Opportunities
Covenants Other Agreements Critical Accounting Policies
Critical Accounting Policies Estimates Current Economic Instability Adversely Affect Operations
Current Report Cutting Insertion Tray
Date Date Time Place
Debt Securities Declaration
Deferred Compensation Program Departure Directors Certain Officers Election
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Dependent Single Limited Source Suppliers Puts Risk Supplier Dependent Single Limited Source Suppliers Subjects Business Results
Derivative Financial Instruments Description
Description Product Development Sales Ire Products Dependent Number Factors Beyond
Dialysis Products Diomed Angiodynamics
Diomed Angiodynamics Biolitec Diomed Angiodynamics Vnus Medical Technologies Vascular Solutions
Diomed Inc Limited Director Compensation Table
Directors Directors Angiodynamics Inc
Disaster Manufacturing Facilities Disrupt Ability Manufacture Products Substantial Disbursement Request Authorization
Dispute Resolution Arbitration Distribution Agreement
Distribution Agreement Extension Dividends
Documents Incorporated Reference Documents Reports Review
Donald Neal Wilkerson Tasha Christian Rita Medical Systems Dosage Administration
Drainage Products Drive Growth Specialty Access Products
Drug Interactions Duration Amendment Termination
E-inventories Earnings Per Common Share
Earnings Per Common Share Contd Effect Certain Corporate Transactions
Effect Recently Issued Pronouncements Effects Recently Issued Pronouncements
Election Directors Eligibility
Eligibility Participation Embolization Beads
Embolization Products Employee Stock Purchase Plan
Employees Employment Contracts Termination Change-in-control Arrangements
End Corporate Objectives Entry Material Definitive Agreement
Environmental Equal Employment Opportunity Harassment
Equity Compensation Plan Information Erisa Information
Estimates Evaluation Disclosure Controls Procedures
Even After Receiving Regulatory Clearance Approval Products Subject Events Default
Exact Name Registrant Specified Charter Except Share Per Data
Exchange Act 1934 Exclusive Distributorship Rights
Executive Compensation Executive Officers
Exhibits Exhibits Financial Statement Schedules
Explanation Explanatory
Export Sales Overseas Distributors Exposed Risks Associated Acquisitions Including Integration Methods Financing
F-property Plant Equipment Cost Face Intense Competition Medical Device Industry Unable Compete
Face Risks Associated Being Member E-z-ems Consolidated Group Facility Expansion
Facility Revolving Line Credit Fail Adequately Protect Intellectual Property Rights Business Suffer
Fail Adequately Protect Intellectual Property Rights Not Able Fail Develop Market New Products Enhance Existing Lose
Fail Develop New Products Enhance Existing Lose Market Failure Attract Additional Capital Require Expand Business Curtail
Failure Reach Agreement Extend Distribution Rights Bead Adverse Fair Dealing
Fair Value Fair Value Contd
Fair Value Financial Instruments Features
Federal Income Tax Consequences Financial Covenants
Financial Fit Financial Guidance
Financial Reporting Process Controls Financial Statement Schedules
Financial Statements Financial Statements Businesses Acquired
Financial Statements Exhibits Financial Statements Supplementary Data
Flowmedica Inc Following Table Sets Forth Fees Awards Other Compensation
Following Table Summarizes Stock Option Exercises Shares Vested Form 10-k
Form 10-q Forward-looking Statements
Future Purchase Obligations General
General Provisions Goodwill Intangible Assets
Goodwill Intangible Assets Contd Governing Law Governed Federal Applicable Lender Extent Not
Government Regulation Grants Awards
Grants Plan-based Awards 2007 Guidance
Hazel Smart Marys Hospital Healthcare Policy Changes Including Pending Proposals Reform System
Healthcare Reform Cause Decrease Demand Interventional Products Hemodialysis Catheters
History Holdback
Holleran Rita Medical Systems Inc However
I-prepaid Royalties Identification Audit Committee
Image-guided Vascular Access Image-guided Vascular Access Products
Important Notice Regarding Availability Proxy Materials Annual Meeting Inability Manage Growth Successfully Implement Internal Reorganization Adverse
Inadequate Levels Reimbursement Governmental Other Third-party Payors Procedures Incentive Awards
Income Taxes Indemnification
Independent Auditors Independent Registered Public Accounting Firm
Index Indications Usage
Industrial Revenue Bonds Industry Experiencing Greater Scrutiny Regulation Governmental Authorities Led
Initial Public Offering Separation Former Parent E-z-em Insurance
Intangible Assets Intellectual Property
Internal Control Over Financial Reporting Internal Revenue Code 162 Considerations
Interventional Oncology Interventional Products
Interventional Surgical Oncology Introduction
Inventories Inventories Net
Investment Cost J-accrued Liabilities
K-long-term Debt Kit
L-related Party Transactions Arrangements Lack Customer Purchase Contracts Limited Order Backlog Make
Leases Legal Compliance General
Legal Proceedings Legislation Policy Changes Reforming Healthcare System Material Adverse
Letter Jan Keltjens President Ceo Libor
Libor Attached Reference Part Promissory Dated 2005 Executed Libor Executed 2005
Limited Ability Engage Acquisitions Other Strategic Transactions Using Line Credit
Line Credit Facility Liquidity Capital Resources
Litigation Litigation Matters
Litigation Provision Net 2008 Results Included Settlement Vnus Long Term Debt
Long-term Debt Long-term Equity-based Incentive Awards
M-retirement Plans Maintaining Experienced Rita Sales Marketing Operational Teams
Managements Report Internal Control Over Financial Reporting Manufacturing
Market Registrants Common Equity Related Stockholder Matters Issuer Marketable Securities
Marketing Master Separation Distribution Agreement
Material Changes Procedures Shareholder Recommendations Nominees Board Directors Mbo Development
Medron Inc Meeting Information
Meetings Meetings Board Committees
Members Families Significant Influence Over Affairs Due Ownership Micro Access
Mid 2007 Minimum Purchase Requirements
Minimums Mirror Stock Option Plans
Miscellaneous Modifications Current Products Require New Marketing Clearances Approvals
More-flow Kit Moreflow Kit
N-stockholders Equity Name Person Filing Proxy Statement Other Registrant
Nanoknife Products Narrative Description Business
Nasdaq Ango Ndex
Nevertouch New Accounting Pronouncements
New Hire Non-qualified Options Nominating Corporate Governance Committee
Nominees Nominees Serve Class Directors Term Expiring 2010 Annual
Nominees Serve Class Directors Term Expiring 2011 Annual Nominees Serve Class Directors Term Expiring 2012 Annual
Non-gaap Measures Non-us
Non-us Regulation Non-vested Stock Awards
Not Develop Maintain Successful Relationships Non-us Distributors Growth Not Maintain Relationships Interventional Physicians Growth Limited Business
Not Maintain Reputation Interventional Physicians Growth Limited Business Not Paid Plans Pay Cash Dividends
Not Realize Anticipated Benefits Acquisition Rita Not Realize Anticipated Benefits Proposed Acquisition Rita Medical
Notes Consolidated Financial Statements Notes Payable Former Parent
Notice Annual Meeting Stockholders Notice Electronic Availability Proxy Statement Annual Report
Notices Number 0-50761
Nursing Mothers O-stock-based Compensation
Obligation Indemnify E-z-em Cause Distribution Not Tax-free Discourage Officers
Offices Oncobionic Inc
Oncology Products Oncology Surgery
Option Activity Option Exercises Stock Vested 2007
Option Exercises Stock Vested 2008 Option Exercises Stock Vested 2009
Option Sar Grants Last Options
Orders Orm Ock Greement
Other Other Directors
Other Events Other Information
Other Matters Other Related Party Transactions
Overachievement Bonus Overview
Ownership Securities P-asset Purchase Agreements
Parent Part
Part Other Information Parties
Parties Claim Products Infringe Intellectual Property Rights Forced Party Claims
Patent Rights Payments Affiliates Other Persons
Payments Etc Payments Government Personnel
Payroll Deductions Stock Purchases Performance
Performance Graph Performance Share Restricted Stock Unit Awards
Peripheral Interventional Medicine Peripheral Vascular
Peripheral Vascular Disease Perquisites
Policy Audit Committee Pre-approval Permissible Non-audit Services Independent Policy Director Attendance Annual Meetings
Policy Related Party Transactions Pregnancy
Prepaid Royalties Preservation Tax-free Status Distribution
Principal Accountant Fees Services Principal Accounting Fees Services
Pro Forma Financial Information Proceeds
Product Liability Claim Brought Against Insurance Coverage Inadequate Product Promotion Intellectual Property
Products Properties
Property Plant Equipment Property Plant Equipment Cost
Proposals Considered Proposed Acquisition Rita Not Completed Incurred Substantial Costs
Proposed Increase Authorized Shares Protection Proper Assets
Provisions Charter Documents Rights Plan Delaware Law Tax Proxy Materials Available
Proxy Materials Available View Receive Pta Dilation Catheters
Pta Products Public Disclosure
Purchase Periods Dates Purchase Price
Purchase Sale Acquired Assets Purchase Sale Shares
Purpose Q-commitments Contingencies
Quantitative Qualitative Disclosures Market Risk Quarterly Corporate Objectives
Quarterly Escrow Quarterly Financial Guidance
Quarterly Operating Results Volatile Cause Stock Price Decline Quarterly Results Operations
Queensbury 2005 Angiodynamics Inc Nasdaq Ango Queensbury 2006 Angiodynamics Inc
Queensbury 2006 Angiodynamics Inc Nasdaq Ango Queensbury 2007
Queensbury 2007 Angiodynamics Inc Nasdaq Ango Queensbury 2007 Angiodynamics Nasdaq Ango
Queensbury 2007-angiodynamics Inc Nasdaq Ango Queensbury 2007-angiodynamics Nasdaq Ango
Queensbury 2008 8212 Queensbury Fremont 2007
Queensbury Fremont Calif 2006 Quorum
Radiofrequency Ablation Product Technology Radiofrequency Ablation Products
Ratification Appointment Independent Registered Public Accounting Firm Receipt Gifts Business Gratuities
Recent Accounting Pronouncements Recent Developments
Recently Adopted Accounting Policies Recently Adopted Accounting Policies Contd
Recently Issued Accounting Pronouncements Recitals
Recommendations Stockholders Director Nominees Record Date Voting Securities
Regarding Availability Proxy Materials Registrants Telephone Number Including Area Code
Registrants Telephone Number Including Area Code 518 798-1215 Regulation Disclosure
Reimbursement Agreement Related Party Consulting Services
Related Party Purchases Related Party Transactions
Relationship Arrangements E-z-em Relocation Expenses
Reorganization Report Independent Registered Public Accounting Firm
Report Repricing Options Sars Reports
Representations Warranties Covenants Representations Warranties Indemnification
Require Additional Capital Failure Attract Curtail Growth Research Development
Research Distribution Agreement Resection Device
Responsibilities Duties Rest World Row Non-exclusive Agreement
Restricted Stock Results Operations
Results Operations Financial Condition Retirement Plans
Revenue Recognition Revocability Proxies Vote
Rfa Disposable Electrodes Rfa Generators
Risk Factors Rita Medical Contacts
Rita Medical Systems Rita Medical Systems Health Benefits Plan
Rita Medical Systems Inc Rita Stock Option Plans
Row Pricing Granted Medcomp Proof Sale Non-usa Market S-quarterly Results Operations
Safe Harbor Sales
Sales Former Parent Parents Affiliates Sales Marketing
Sales Within Territory Sarbanes-oxley Act 2002
Scientific Advisory Board Securities Exchange
Securities Exchange Act 1934 Securities Registered Pursuant Act
Security Ownership Certain Beneficial Owners Management Related Stockholder Segment Geographic Information
Segment Geographic Information Contd Segment Geographic Information- Contd
Set Severance Benefits
Share Proration Shareholder Representative
Shipping Shipping Handling Costs
Short Term Cash Incentive Opportunity Signature
Signature Page Follows Signatures
Solicitation Proxies Some Directors Conflicts Interest Because They Also E-z-em
Some Directors Conflicts Interest Because They Also Officers Some Suppliers Fail Comply Fdas Quality System Regulation
Special Limitations Specifications
Standard Bonus Levels Standards
State Other Jurisdiction Incorporation Statement Agreement
Steven Law Administrator Stock
Stock Based Compensation Stock Incentive Award Plan
Stock Option Plan Stock Option Plans
Stock Options Stock Price Volatile Cause Value Decline Subject Securities
Stock Purchase Agreement Stock Subject Plan
Stock Subject Plan Award Limits Stock-based Compensation
Stockholder Influence Affairs Due Ownership Significant Amount Stock Stockholder Lawsuit Been Filed Against Rita Directors Challenging
Stockholder Proposals Nominations Stockholder Rights
Stockholder Rights Plan Subcontracting
Subject Fines Penalties Injunctions Determined Promoting Products Unapproved Subject Healthcare Fraud Abuse Regulations Result Significant Liability
Submission Matters Vote Security Holders Subsequent Event
Subsidiaries Angiodynamics Inc Summary
Summary Amendment Merger Agreement Summary Compensation Table 2007
Summary Description 2004 Plan Amended Summary Federal Income Tax Consequences 2004 Plan
Summary Plan Amended Supplied
Supplier Concentrations Suppliers Fail Comply Fdas Quality System Regulation Other
Supply Distribution Rights Agreement Survival Indemnification
T-quarterly Results Operations T-subsequent Event
Table Below Presents Data Entered Table Contents
Tactical Fit Targeted Renal Therapy
Tax Allocation Indemnification Agreement Tax Treatment Angiodynamics
Taxable Adjustable Rate Notes Taxes
Term Termination Termination
Termination Fee Termination Hsr Waiting Period
Third-party Reimbursement Thirteen 2004 2003
Thirteen 2005 2004 Thirteen 2006 2005
Thirteen 2007 2006 Thirty-nine 2005 2004
Thirty-nine 2006 2005 Thirty-nine 2007 2006
Thrombolytic Products Title Class
Trade Transfer
Transfer Letter Credit Reduction Termination Related Matters Transfer Price
Transition Report Pursuant Securities Exchange Act 1934 Transjugular Access
Tray Treatment Incomplete Terms
Twenty-six 2004 2003 Twenty-six 2005 2004
Twenty-six 2006 2005 Undetected Defects Increase Costs Impair Market Acceptance Products
United States United States Fda Regulation
United States Regulation Unrecognized Compensation Cost
Unregistered Sales Equity Securities Proceeds Usc 1051
Vascular Access Product Line Becomes Angos Largest Segment Vascular Access Products
Venacure Venacure Products
Venous Adapters Venous Products
Vnus Medical Technologies Diomed Vascular Solutions Angiodynamics Vote
Votes Required Voting
Voting Proxies Waivers Code
Warnings Warrants
Withdrawal Termination Purchase Rights Wwwproxyvotecom
Year-end Individual Objectives Mbos 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki